Telemedicine in hepatology: current applications and future directions


Posted: 2021-09-10 19:00:00
Review Liver Transpl . 2021 Sep 10. doi: 10.1002/lt.26293. Online ahead of print. Affiliations Expand Affiliations 1 Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Arizona College of Medicine - Phoenix, Phoenix, AZ, USA. 2 Banner - University Medical Center Phoenix, Phoenix, AZ, USA. 3 Seton Hall University, South Orange, NJ, USA. 4 Division of Gastroenterology, Department of Medicine, Duke University, Durham, NC, USA. 5 Division of Gastroenterology, Department of Medicine, Olive View-UCLA Medical Center, Sylmar, CA, USA. 6 David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Item in Clipboard Review Brian M Fung et al. Liver Transpl. 2021. Show details Display options Display options Format Liver Transpl . 2021 Sep 10. doi: 10.1002/lt.26293. Online ahead of print. Affiliations 1 Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Arizona College of Medicine - Phoenix, Phoenix, AZ, USA. 2 Banner - University Medical Center Phoenix, Phoenix, AZ, USA. 3 Seton Hall University, South Orange, NJ, USA. 4 Division of Gastroenterology, Department of Medicine, Duke University, Durham, NC, USA. 5 Division of Gastroenterology, Department of Medicine, Olive View-UCLA Medical Center, Sylmar, CA, USA. 6 David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Item in Clipboard CiteDisplay options Display options Format Abstract Telemedicine refers to the use of information and communication technologies for providing health care at a distance. Through the use of telecommunication technologies such as cellphones, computers, and other electronic devices, healthcare providers are able to conduct patient visits, mentor/train other providers, and monitor patients' chronic diseases remotely, potentially hundreds or thousands of miles away. Over the past two decades, the use of telemedicine has grown in the field of hepatology. In this review, we provide a focused primer on telemedicine and its current applications in hepatology. In particular, we discuss the use of telemedicine in the management of chronic hepatitis C, the complications of liver disease, as well as pre-liver transplantation evaluation and post-transplantation care. In addition, we provide a synopsis of the effect of the COVID-19 pandemic on the use of telemedicine in hepatology. Keywords: COVID-19; chronic liver disease; hepatitis C; liver transplantation; teleconsultation; telehealth; telementoring; video conference. This article is protected by copyright. All rights reserved. Publication types [x] Cite Copy Format: Send To [x]

参考サイト PubMed: covid-19



バイオクイックニュース日本語版:COVID-19特集

バイオクイックニュース日本語版
6月 23, 2021 バイオアソシエイツ

スクリプス研究所の研究で、COVID-19の治療薬候補として10種類以上の既存薬が特定された。

世界で最も包括的な COVID-19 治療薬の再利用コレクションを調査した結果、現在進行中の世界的大流行の原因となっているコロナウイルスに対して抗ウイルス活性を有する90種類の既存の医薬品または医薬品候補を特定した。これらの化合物のうち、スクリプス研究所の研究では、COVID-19の経口薬として再利用できる可能性が高い、臨床承認された4つの薬剤と、その他の開発段階にある9つの化合物を特定した。 2021年6月3日にNature…